The effectiveness of tamsulosin in treating women with voiding difficulty

International Journal of Urology : Official Journal of the Japanese Urological Association
Shang-Jen ChangHong-Jeng Yu

Abstract

To prospectively evaluate the effectiveness of tamsulosin in treating women with voiding difficulty. Female patients presenting chronic, bothersome voiding symptoms, combined with subnormal uroflow were treated with 0.2 mg tamsulosin daily for six weeks. Outcome analyses included the International Prostate Symptom Score and uroflowmetry with post-void residual urine. Patients achieving a 50% or greater reduction in their voiding symptom score, combined with a 30% or greater increment in their maximal flow rate were regarded as having a good therapeutic response. Subgroup analysis was performed in patients classified as having bladder outlet obstruction, or detrusor underactivity based on pressure-flow study, excluding those with indwelling catheterization or intermittent self-catheterization as well as those with anatomic obstruction. Ninety-seven patients met the study inclusion criteria and were enrolled. Significant improvements in voiding symptom score, storage symptom score, maximal flow rate, post-void residual urine and voiding efficiency were observed in all patients while on tamsulosin. A good therapeutic response was observed in 35.1% of patients. Of these, 33 were classified as having bladder outlet obstruction and 5...Continue Reading

References

Feb 11, 1986·European Journal of Pharmacology·F YablonskyJ P Dausse
Oct 1, 1996·Scandinavian Journal of Urology and Nephrology·B J HansenE H Larsen
Apr 21, 1999·The Journal of Urology·V W NittiJ Gitlin
Feb 22, 2002·Neurourology and Urodynamics·Paul AbramsUNKNOWN Standardisation Sub-committee of the International Continence Society
Sep 23, 2003·The Journal of Urology·Paul AbramsUNKNOWN European Tamsulosin Neurogenic Lower Urinary Tract Dysfunction Study Group
Dec 10, 2003·Urology·Karl Erik Andersson
Jan 7, 2004·International Journal of Urology : Official Journal of the Japanese Urological Association·Tomonori YamanishiKen-ichiro Yoshida
Aug 15, 2006·International Journal of Urology : Official Journal of the Japanese Urological Association·Momokazu GotohShinichi Ohshima
Sep 6, 2006·The Journal of Urology·Thomas M KesslerFiona C Burkhard
Oct 31, 2006·The Journal of Urology·Tulsi V AkikwalaVictor W Nitti
Jan 3, 2007·Journal of the American Geriatrics Society·John A Taylor, George A Kuchel

❮ Previous
Next ❯

Citations

Sep 18, 2012·International Urology and Nephrology·Laura E Meyer, Jamie N Brown
Jul 17, 2010·Current Urology Reports·John A Occhino, Steven W Siegel
Nov 30, 2013·International Urogynecology Journal·Jia-Fong JhangHann-Chorng Kuo
Sep 23, 2014·International Urology and Nephrology·Pradeep TyagiNaoki Yoshimura
Sep 23, 2014·International Urology and Nephrology·Phillip P SmithPeter Levanovich
Feb 16, 2016·Current Urology Reports·Himanshu Aggarwal, Philippe E Zimmern
Jul 15, 2015·Experimental and Therapeutic Medicine·Peng ZhangXiao-Kan Xiong
Mar 5, 2016·International Urology and Nephrology·Xing Li, Limin Liao
Mar 21, 2009·Neurourology and Urodynamics·Anne P Cameron, Jerzy B Gajewski
Oct 30, 2014·Expert Opinion on Pharmacotherapy·Nitya Abraham, Howard B Goldman
Dec 28, 2017·Investigative and Clinical Urology·Dae Kyung Kim
Jan 4, 2018·Ci Ji Yi Xue Za Zhi = Tzu-chi Medical Journal·Yuan-Hong JiangHann-Chorng Kuo
Aug 10, 2018·F1000Research·Su-Min Lee, Hashim Hashim
Nov 20, 2019·Current Opinion in Ophthalmology·Andrzej Grzybowski, Piotr Kanclerz
Dec 6, 2017·Expert Review of Clinical Pharmacology·Seyedeh-Sanam Ladi-SeyedianAbdol-Mohammad Kajbafzadeh
May 30, 2020·Current Bladder Dysfunction Reports·Katherine K ShapiroChristopher J Chermansky
Mar 13, 2014·The Annals of Pharmacotherapy·Katie Boyd, Olga Hilas
May 9, 2019·Revista da Associação Médica Brasileira·Carlos Alberto Ricetto SacomaniWanderley M Bernardo
May 11, 2017·Revista da Associação Médica Brasileira·José Carlos TruzziUNKNOWN Brazilian Society of Urology (SBU)
Jul 11, 2020·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·F TahaS Larre
Jun 1, 2021·International Neurourology Journal·Su Jin KimKhae Hawn Kim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.